Hi Kevin,Well the market is a scary place right now to be...

Hi Kevin,
Well the market is a scary place right now to be getting into anything 'in a big way', especially a biospec.
But PRR has a few things in its favour in my humble, amatuer opinion.
1. It has looked quite determined not to go much lower than here. Even on Aug 4 it bounced late to 16.5c.
2. It seems to be in a channel between 15ish and 21.5c and I presume it can go back up there without much technivcal resistance in spite of (?) an overall downtrend.
3. That support line should hold it up as it pushes through the downtrend line from July (barring bad news or bad macro stuff). This is days away (or maybe one good day).
4. NASDAQ has become a byword with PRR (since the listing is 10 or 11 months late). However the fact that the last murmured excuses were all about PRR complying with International Accounting Standards, and the compliant Annual Report has now been released, suggests it could finally be close. Don't let anyone tell you it won't have an effect. The ADR Listing lists bundles of Australian Shares on the NASDAQ. NO NEW SUPPLY, but new biotech savvy demand...
5. Other than that there'll be regular good news (we hope) with Commercialisation in Australia soon, updates on Oral Cervical Cancer Vaccine. You never know if the market recovers Dendreon might even go back to reflecting glory on us...
Not giving anyone advice here. But if I did it would be only 'invest' what you can afford to lose, cut your losses when you need to and re-enter boldly when it looks safe. Life is long, work is hard. Money is hard to make, and easy to lose. Be careful...? Good luck...
:-)